Tag: Diabetes: Type II

Study also revealed no increased risk for major adverse cardiovascular events for patients on a GLP-1 RA versus those not on a GLP-1 RA

No significant increase in hazard ratios seen for GI events for semaglutide versus dulaglutide, tirzepatide versus dulaglutide, tirzepatide versus semaglutide

Any aspirin use linked to lower hazards of MI, ischemic stroke, with greater benefit in high-frequency use group

Lower risk for MCI and dementia also seen with moderate, high cardiovascular health in those with high polygenic risk score

Childhood diabetes prevention programs should address broader issues of food access and quality, authors say

20 percent greater mortality benefit seen in obstructive sleep apnea population

New ICD-10 diagnosis code is for patients with history of type 2 diabetes who bring blood sugar levels to a non-diabetic range below 6.5% for at least three months

Even higher use seen in patients without type 2 diabetes

Authors say in those without diabetes, continuous glucose monitors are not a substitute for HbA1c

Findings seen for both medication and surgical procedures in people with obesity and type 2 diabetes